Generic Drugs & Pharmacy News

Image description

Upsher-Smith launches Anafranil generic

The clomipramine hydrochloride capsules market had U.S. sales of approximately $172 million for the 12 months ending December 2016, according to IMS Health.

Image description

Report: 5 takeaways from the CBO’s analysis of AHCA

The Congressional Budget Office on Monday released its assessment of the American Health Care Act, the House GOP's proposal to replace Obamacare, and The Hill is outlining five of the biggest takeaways. Among them are the 24 million individuals who would be uninsured by 2026, with 14 million losing coverage next year, as well as the expected reduction in the federal deficit that the bill would bring about. The bill would also create extensive changes to Medicaid.  (The Hill)

Image description

Lawmakers revise generic drug legislation

H.R. 749 is intended to require the U.S. Food and Drug Administration to act upon applications for generic drugs within 180 days of being filed that are in short supply or when there are too few manufacturers on the market is being revised.

Image description

Report: New data highlights imatinib’s efficacy

Some 83% of patients with chronic myelogenous leukemia taking Gleevec (imatinib) can live 10 years or longer, according to new data published in the New England Journal of Medicine, NBC News is reporting. The study looked at the original 1,100 patients in the Gleevec trial, though in the years since approval several generics have hit the market. The data shows the drug, which targets a CML-specific genetic mutation, has a 10-year survival rate of nearly 83%. (NBC News)
 

Image description

Lupin launches Temovate generic

Clobetasol Propionate Topical Solution USP, 0.05% is indicated for short-term topical treatment of inflammatory and pruritic manifestations of moderate to severe corticosteroid-responsive dermatoses of the scalp.